The “Tandem Mass Spectrometry” device for early-stage fetal and neonatal diagnostics has been officially delivered

For the first time in Mongolia, advanced Tandem Mass Spectrometry technology for early-stage fetal and neonatal diagnostics has been introduced and officially delivered to the National Center for Maternal and Child Health (NCMCH).

This milestone initiative was spearheaded by Ms. N. Tselmuun, President of Mongolyn Alt (MAK) LLC and UNICEF National Ambassador, reflecting a strong commitment to strengthening the nation’s healthcare system and improving child health outcomes.

The new device enables early detection of more than 30 types of fetal and neonatal diseases that were previously impossible to diagnose in Mongolia. By identifying conditions at an early stage, the technology provides opportunities to prevent lifelong illnesses and disabilities, while also saving countless lives.

“This marks a new chapter in Mongolia’s healthcare capacity. With this technology, every child will have a greater chance at a healthy start in life,” said Ms. N. Tselmuun.

The handover of the device will allow for sample collection and analysis from all 21 provinces, ensuring nationwide access to advanced diagnostic services.

Mongolyn Alt (MAK) LLC and UNICEF Mongolia extend their heartfelt gratitude to all partner organizations, medical teams, and individuals whose efforts and support made this achievement possible.